MCOL August 6, 2020
Pre-pandemic, much of the healthcare oxygen in any room was consumed by discussions and debate over pharmaceutical costs. While now, the focus in that arena will be on vaccine costs, certainly Rx cost concerns have been shoved by most to the back burner. And now a new report may help provide some justification in that regard.
The IQVIA Institute for Human Data Science has just released a new 41-page report: Medicine Spending and Affordability in the U.S.: Understanding Patient Costs for Medicines, that found “the vast majority of patients in the United States are experiencing lower out-of-pocket costs for their drugs, paying a smaller share of costs and seeing a downward trend in their costs on average.” As a reminder,...
Today's Sponsors
Today's Sponsor